Cited by 626Alzheimer's disease research and treatmentsSphingolipid Metabolism and SignalingDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, Xianlin, M. Holtzman, David, W. McKeel, Daniel, Kelley, John, Morris, John C.·2002·Journal of Neurochemistry

DOI 10.1046/j.1471-4159.2002.00997.x

Open this paper in CoChat — free account

Abstract

In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2002.00997.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,612
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citation
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624

Show all 56 references

Research works printed but not linked: 5

10.1139/y59-099 · DOI · Paper page
10.1042/bj3520079 · DOI
Kolodny E. H., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2693
Mattson M. P., 1997, Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Suzuki K., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2671

Sorted by citations

Items 301–400 of 625

Membrane Microdomain Signaling
Mattson, M. P. (2005) · Humana Press eBooks · doi:10.1385/159259803x · Cited by 39
Microglial cGAS Deletion Preserves Intercellular Communication and Alleviates Amyloid‐β‐Induced Pathogenesis of Alzheimer's Disease
He, S., Li, X., Mittra, N., Bhattacharjee, A., Wang, H., Song, S., Zhao, S., Liu, F., & Han, X. (2025) · Advanced Science · doi:10.1002/advs.202410910 · Cited by 34
Self-citation
Lipid Mediators and Their Metabolism in the Nucleus: Implications for Alzheimer's Disease
Farooqui, A. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111085 · Cited by 34
Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer’s Disease and Inflammation at the Pre- and Early Stages of Dementia
Teitsdottir, U. D., Halldórsson, S., Rolfsson, Ó., Lund, S. H., Jónsdóttir, M. K., Snædal, J., & Petersen, P. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200964 · Cited by 39
Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes
Chen, S., Lee, J., Zeng, C., Chen, H., Hsu, C. Y., & Xu, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03774.x · Cited by 34
A Signaling Lipid Associated with Alzheimer’s Disease Promotes Mitochondrial Dysfunction
Kennedy, M. A., Moffat, T. C., Gable, K. S., Ganesan, S., Niewola‐Staszkowska, K., Johnston, A., Nislow, C., Giaever, G. N., Harris, L. J., Loewith, R., et al. (2016) · Scientific Reports · doi:10.1038/srep19332 · Cited by 38
Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases
Eckhardt, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054908 · Cited by 36
Anti-depressant effect of Zhi-zi-chi decoction on CUMS mice and elucidation of its signaling pathway
Chai, C., Jin, B. R., Yan, Y., Yuan, Q., Wen, H., Tao, W., Cui, X., Shan, C., & Yu, S. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113283 · Cited by 34
Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicity
McInnis, J. J., Sood, D., Guo, L., Dufault, M. R., García, M. G., Passaro, R., Gao, G., Zhang, B., & Dodge, J. C. (2024) · Communications Biology · doi:10.1038/s42003-024-07231-0 · Cited by 33
MAM and C99, key players in the pathogenesis of Alzheimer’s disease
Pera, M., Montesinos, J., Larrea, D., Agrawal, R. R., VELASCO, K. R., Stavrovskaya, I. G., Yun, T. D., & Área-Gómez, E. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.016 · Cited by 35
The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
Smirnov, D., Mazin, P., Osetrova, M., Stekolshchikova, E., & Khrameeva, E. E. (2021) · Metabolites · doi:10.3390/metabo11110713 · Cited by 31
Cytosolic phospholipase A2α upregulation mediates apoptotic neuronal death induced by aggregated amyloid-β peptide1–42
Sagy‐Bross, C., Hadad, N., & Lévy, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.007 · Cited by 32
Defining Changes in the Spatial Distribution and Composition of Brain Lipids in the Shiverer and Cuprizone Mouse Models of Myelin Disease
Maganti, R. J., Hronowski, X. L., Dunstan, R. W., Wipke, B. T., Zhang, X., Jandreski, L., Hamann, S., & Juhász, P. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418815860 · Cited by 33
Metabolomic Study of Hibernating Syrian Hamster Brains: In Search of Neuroprotective Agents
González-Riaño, C., León‐Espinosa, G., Regalado-Reyes, M., Garcı́a, A., DeFelipe, J., & Barbas, C. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00816 · Cited by 31
Mass spectrometry based lipid(ome) analyzer and molecular platform: a new software to interpret and analyze electrospray and/or matrix‐assisted laser desorption/ionization mass spectrometric data of lipids: a case study from Mycobacterium tuberculosis
Sabareesh, V., & Singh, G. (2013) · Journal of Mass Spectrometry · doi:10.1002/jms.3163 · Cited by 30
Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer’s Disease Using Direct Infusion Mass Spectrometry
Anand, S., Barnes, J. M., Young, S. A., García, D. M., Tolley, H. D., Kauwe, J. S. K., & Graves, S. W. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170035 · Cited by 31
Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer’s Disease
Qi, Y.-Y., Heng, X., Yao, Z.-Y., Qu, S.-Y., Ge, P., Zhao, X., Ni, S.-J., Guo, R., Yang, N.-Y., Zhang, Q.-C., et al. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s357061 · Cited by 30
Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy
Tringali, C., & Giussani, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147806 · Cited by 33
Microglial carbohydrate-binding receptors for neural repair
Linnartz‐Gerlach, B., Bodea, L., & Neumann, H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1342-7 · Cited by 30
Practical metabolomics in drug discovery
Wilcoxen, K., Uehara, T., Myint, K. T., Sato, Y., & Oda, Y. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003631854 · Cited by 30
Choline-Containing Phospholipids in Microdissected Human Alzheimer’S Disease Brain Senile Plaque Versus Neuropil
Gaudin, M., Panchal, M., Auzeil, N., Duyckaerts, C. J., Brunelle, A., Laprévôte, O., & Touboul, D. (2012) · Bioanalysis · doi:10.4155/bio.12.189 · Cited by 28
Atmospheric Pressure Photoionization as a Powerful Tool for Large-Scale Lipidomic Studies
Gaudin, M., Imbert, L., Libong, D., Chaminade, P., Brunelle, A., Touboul, D., & Laprévôte, O. (2012) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-012-0341-y · Cited by 30
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
Custodia, A., Romaus‐Sanjurjo, D., Aramburu-Núñez, M., Álvarez-Rafael, D., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Leira, Y., Peleteiro, J. M. P., Aldrey, J. M., Sobrino, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158082 · Cited by 31
White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
Sharp, F. R., DeCarli, C. S., Jin, L., & Zhan, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096206 · Cited by 33
Multiplexed molecular descriptors of pressure ulcers defined by imaging mass spectrometry
Taverna, D., Nanney, L. B., Pollins, A. C., Sindona, G., & Caprioli, R. M. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00738.x · Cited by 29
Sulfatides facilitate apolipoprotein E‐mediated amyloid‐β peptide clearance through an endocytotic pathway
Zeng, Y., & Han, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05481.x · Cited by 29
Self-citation
Pathology and Current Treatment of Neurodegenerative Sphingolipidoses
Eckhardt, M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8133-7 · Cited by 30
Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease
Òbis, È., Sol, J., Andrés‐Benito, P., Martin‐Garí, M., Mota‐Martorell, N., Galo‐Licona, J. D., Piñol‐Ripoll, G., Portero‐Otín, M., Ferrer, I., Jové, M., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0217 · Cited by 28
Quantitative profiling of phosphatidylcholine and phosphatidylethanolamine in a steatosis/fibrosis model of rat liver by nanoflow liquid chromatography/tandem mass spectrometry
Ahn, E. J., Kim, H., Chung, B. C., Kong, G., & Moon, M. H. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.04.031 · Cited by 28
Ceramide and Cholesterol: Possible Connections Between Normal Aging of the Brain and Alzheimer's Disease. Just hypotheses or molecular pathways to be identified?
Costantini, C., Kolasani, R., & Puglielli, L. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.004 · Cited by 29
Sphingosine kinase 2 potentiates amyloid deposition but protects against hippocampal volume loss and demyelination in a mouse model of Alzheimer’s disease
Lei, M., Teo, J. D., Song, H., McEwen, H. P., Yup Lee, J., Couttas, T. A., Duncan, T., Chesworth, R., Bertz, J., Przybyla, M., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0524-19.2019 · Cited by 27
Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)
de la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 28
Neuronal Membrane Lipids – Their Role in the Synaptic Vesicle Cycle
Lim, L., & Wenk, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_9 · Cited by 27
Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?
Creegan, R., Hunt, W., McManus, A., & Rainey‐Smith, S. R. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000926 · Cited by 29
What can lipidomics tell us about the pathogenesis of Alzheimer disease?
Xiang, Y., Lam, S. M., & Shui, G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0207 · Cited by 27
A turn of the sulfatide in Alzheimer's disease
Irizarry, M. C. (2003) · Annals of Neurology · doi:10.1002/ana.10642 · Cited by 27
Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery
Kalkman, H. O., & Smigielski, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04989-0 · Cited by 29
Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice
Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2025) · Nature Communications · doi:10.1038/s41467-025-64161-z · Cited by 33
Self-citation
Sphingolipids and impaired hypoxic stress responses in Huntington disease
Burtscher, J., Pepe, G., Maharjan, N., Riguet, N., Pardo, A. D., Maglione, V., & Millet, G. P. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101224 · Cited by 27
Alzheimers Disease, Ceramide, Visfatin and NAD
Adams, J. D., Jr. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708787122969 · Cited by 26
Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Zhang, J., & Jia, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151158 · Cited by 26
Autoreactivity to Sulfatide by Human Invariant NKT Cells
Stax, A. M., Tuengel, J., Girardi, E., Kitano, N., Allan, L. L., Liu, V., Zheng, D., Panenka, W. J., Guillaume, J., Wong, C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601976 · Cited by 26
Intracellular drug delivery by sulfatide-mediated liposomes to gliomas
Shao, K., Hou, Q., Duan, W., Go, M., Wong, K. P., & Li, Q. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.024 · Cited by 26
Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target
Jembrek, M. J., Leko, M. B., Pivac, N., Hof, P. R., & Šimić, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0144-z · Cited by 25
Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway
Zheng, M., Liu, Z., Mana, L., Qin, G., Huang, S., Gong, Z., Tian, M., He, Y., & Wang, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114264 · Cited by 25
Involvement of Ceramide in Ischemic Tolerance Induced by Preconditioning with Sublethal Oxygen-Glucose Deprivation in Primary Cultured Cortical Neurons of Rats
Bhuiyan, M. I. H., Islam, M. N., Jung, S. Y., Yoo, H. H., Lee, Y. S., & Jin, C. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.11 · Cited by 25
Peripheral sphingolipids are associated with variation in white matter microstructure in older adults
Gonzalez, C. E., Venkatraman, V. K., An, Y., Landman, B. A., Davatzikos, C. A., Bandaru, V. V. R., Haughey, N. J., Ferrucci, L., Mielke, M. M., & Resnick, S. M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.008 · Cited by 25
High-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer’s Disease Pathogenesis
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2018) · Metabolites · doi:10.3390/metabo8030052 · Cited by 24
Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice
van Zyl, R. M., Gieselmann, V., & Eckhardt, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06458.x · Cited by 25
Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells
Theiss, E. L., Griebsch, L. V., Lauer, A. A., Janitschke, D., Erhardt, V. K. J., Haas, E. C., Kuppler, K. N., Radermacher, J., Walzer, O., Portius, D., et al. (2022) · Cells · doi:10.3390/cells11162574 · Cited by 24
Alzheimer’s disease manifests abnormal sphingolipid metabolism
Uranbileg, B., Isago, H., Sakai, E., Kubota, M., Saito, Y., & Kurano, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1368839 · Cited by 24
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Comprehensive Approach for Sequential MALDI-MSI Analysis of Lipids, N-Glycans, and Peptides in Fresh-Frozen Rodent Brain Tissues
Lee, Y., Kaya, I., Wik, E., Baijnath, S., Lodén, H., Nilsson, A., Zhang, X., Sehlin, D., Syvänen, S., Svenningsson, P., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05665 · Cited by 25
Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult
Tang, H., Tang, Y., Li, N., Lin, H., Li, W., Shi, Q., Zhang, W. K., Zhang, P., Dong, Z., Shen, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131569 · Cited by 24
Lipidomic analysis of cerebrospinal fluid by mass spectrometry–based methods
Colsch, B., Seyer, A., Boudah, S., & Junot, C. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9798-0 · Cited by 25
Strategy for Comprehensive Profiling and Identification of Acidic Glycosphingolipids Using Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry
Hu, T., Jia, Z., & Zhang, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02023 · Cited by 24
Inhibition of Serine Palmitoyltransferase by a Small Organic Molecule Promotes Neuronal Survival after Astrocyte Amyloid Beta 1–42 Injury
Vita, T. D., Albani, C., Realini, N., Migliore, M., Basit, A., Ottonello, G., & Cavalli, A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00556 · Cited by 24
Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids
Blank, M., & Hopf, C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15216 · Cited by 24
Sulfatide-tenascin interaction mediates binding to the extracellular matrix and endocytic uptake of liposomes in glioma cells
Shao, K., Hou, Q., Go, M., Duan, W., Cheung, N. S., Feng, S., Wong, K. P., Yoram, A., Zhang, W., Huang, Z., et al. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6419-1 · Cited by 24
Diminished brain resilience syndrome: A modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration
Seneff, S., & Morley, W. A. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.134731 · Cited by 25
Lipidome Evolution in Mammalian Tissues
Khrameeva, E. E., Kurochkin, I., Bożek, K., Giavalisco, P., & Khaitovich, P. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy097 · Cited by 24
Mass Spectrometry Imaging Shows Modafinil, A Student Study Drug, Changes the Lipid Composition of the Fly Brain
Philipsen, M. H., Ranjbari, E., Gu, C., & Ewing, A. G. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202105004 · Cited by 22
Chemical analysis of the human brain by imaging mass spectrometry
Ajith, A., Sthanikam, Y., & Banerjee, S. (2021) · The Analyst · doi:10.1039/d1an01109j · Cited by 23
Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications
Xu, Z., He, S., Begum, M. M., & Han, X. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0676 · Cited by 24
Self-citation
Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
Hwangbo, N., Zhang, X., Raftery, D., Gu, H., Hu, S., Montine, T. J., Quinn, J. F., Chung, K. A., Hiller, A., Wang, D., et al. (2022) · Metabolites · doi:10.3390/metabo12040277 · Cited by 24
Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4 : Application of single cell‐type lipidomics
Asante, I., Louie, S. G., & Yassine, H. N. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14907 · Cited by 23
Regulatory effect of sulphatides on BKCachannels
Chi, S., & Qi, Z. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706947 · Cited by 22
Investigating the Medial Temporal Lobe in Alzheimer’s Disease and Mild Cognitive Impairment, with Turboprop Diffusion Tensor Imaging, MRI-volumetry, and T 2-relaxometry
Arfanakis, K., Gui, M., Tamhane, A. A., & Carew, J. D. (2007) · Brain Imaging and Behavior · doi:10.1007/s11682-007-9001-4 · Cited by 22
Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer’s Disease
Nuñez, K. M., Kay, J., Krotow, A., Tong, M., Agarwal, A., Cadenas, E., & de la Monte, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150916 · Cited by 22
Effects of dietary glucocerebrosides from sea cucumber on the brain sphingolipid profiles of mouse models of Alzheimer's disease
Song, Y., Cong, P., Lu, L., Wang, Y., Tang, Q., Zhang, H., Xu, J., & Xue, C. (2017) · Food & Function · doi:10.1039/c6fo01659f · Cited by 22
Remyelination: A Potential Therapeutic Strategy for Alzheimer’s Disease?
Sun, J., Zhou, H., Bai, F., Zhang, Z., & Ren, Q. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170036 · Cited by 22
Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis
Grimm, M. O. W., Lauer, A. A., Grösgen, S., Thiel, A., Lehmann, J., Winkler, J., Janitschke, D., Herr, C., Beißwenger, C., Bals, R., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.015 · Cited by 22
BACE1 RNAi Restores the Composition of Phosphatidylethanolamine-Derivates Related to Memory Improvement in Aged 3xTg-AD Mice
Villamil-Ortiz, J. G., Barrera-Ocampo, A. A., Piedrahita, D., Velásquez, C., Arias-Londoño, J. D., & Cardona‐Gómez, G. P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00260 · Cited by 22
Role of dietary and nutritional interventions in ceramide-associated diseases
Wang, S., Jin, Z., Wu, B., Morris, A. J., & Deng, P. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100726 · Cited by 22
Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe
Crivelli, S. M., van Kruining, D., Luo, Q., Stevens, J., Giovagnoni, C., Paulus, A., Bauwens, M., Berkeš, D., de Vries, H. E., Mulder, M. T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76335-4 · Cited by 22
Plasmalogen Deficit: A New and Testable Hypothesis for the Etiology of Alzheimer’s Disease
Paul, L., Amin, M., Mankidy, R., Smith, T. M., & Dayan, B. (2011) · InTech eBooks · doi:10.5772/17630 · Cited by 21
Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
Charkiewicz, K., Błachnio-Zabielska, A. U., Zbucka-Krętowska, M., Wołczyński, S., & Laudański, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127732 · Cited by 21
Food-induced changes of lipids in rat neuronal tissue visualized by ToF-SIMS imaging
Pour, M. D., Jennische, E., Lange, S., Ewing, A. G., & Malmberg, P. (2016) · Scientific Reports · doi:10.1038/srep32797 · Cited by 21
Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging
Šmidák, R., Köfeler, H. C., Hoeger, H., & Lübec, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180675 · Cited by 21
Sulfatide Deficiency, an Early Alzheimer’s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks
Ding, L., Palavicini, J. P., Pan, M., Qiu, S., Wang, H., Shen, Q., Dupree, J. L., & Han, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010233 · Cited by 19
Self-citation
Frontal Cortex Lipid Alterations During the Onset of Alzheimer’s Disease
Moreno‐Rodríguez, M., Perez, S. E., Martínez‐Gardeazabal, J., Manuel, I., Malek‐Ahmadi, M. H., Rodríguez‐Puertas, R., & Mufson, E. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231485 · Cited by 21
Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons
Kilkus, J. P., Goswami, R., Dawson, S., Testai, F. D., Berdyshev, E. V., Han, X., & Dawson, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05490.x · Cited by 20
Self-citation
Alterations in Mouse Brain Lipidome after Disruption of CST Gene: A Lipidomics Study
Wang, C., Wang, M., Zhou, Y., Dupree, J. L., & Han, X. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8626-0 · Cited by 20
Self-citation
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry
Panda, P., Ferreira, C. R., Cooper, B. R., Schaser, A. J., & Aryal, U. K. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00688 · Cited by 19
Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer’s Disease
Sakr, F., Initiative, A. D. N., Dyrba, M., Bräuer, A., & Teipel, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201504 · Cited by 19
Ceramide and Related‐Sphingolipid Levels Are Not Altered in Disease‐Associated Brain Regions of APPSL and APPSL/PS1M146L Mouse Models of Alzheimer′s Disease: Relationship with the Lack of Neurodegeneration?
Barrier, L., Fauconneau, B., Noël, A., & Ingrand, S. S. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/920958 · Cited by 19
Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system
Garcia‐Gil, M., Pierucci, F., Vestri, A., & Meacci, E. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13726 · Cited by 18
Linking glycosphingolipids to Alzheimer’s amyloid-ß: extracellular vesicles and functional plant materials
Yuyama, K., & Igarashi, Y. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10066-8 · Cited by 21
A comprehensive profiling of sulfatides in myelin from mouse brain using liquid chromatography coupled to high-resolution accurate tandem mass spectrometry
Pintado‐Sierra, M., García‐Álvarez, I., Bribián, A., Medina-Rodriguez, E. M., Lebrón‐Aguilar, R., Garrido, L., de Castro, F., Fernández‐Mayoralas, A., & Quintanilla-López, J. E. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.11.054 · Cited by 18
Arylsulfatases A and B: From normal tissues to malignant tumors
Kovács, Z., Jung, I., & Gurzu, S. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152516 · Cited by 18
Sphingolipid profiles are altered in prefrontal cortex of rats under acute hyperglycemia
Fiedorowicz, A., Prokopiuk, S., Żendzian‐Piotrowska, M., Chabowski, A., & Car, H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.022 · Cited by 18
High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS
Blomqvist, M., Borén, J., Zetterberg, H., Blennow, K., Månsson, J., & Ståhlman, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.d076588 · Cited by 18
Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
Sakr, F. A., Dyrba, M., Bräuer, A. U., Teipel, S. J., & Initiative, A. D. N. (2022) · DZNE Pub · Cited by 17
Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology
Carmo, S. D., Kautzmann, M.-A. I., Bhattacharjee, S., Jun, B., Steinberg, C., Emmerson, J. T., Malcolm, J. C., Bonomo, Q., Bazan, N. G., & Cuello, A. C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03184-7 · Cited by 18
Analysis of complex lipidomes
Uphoff, A., Hermansson, M., Haimi, P., & Somerharju, P. J. (2008) · Elsevier eBooks · doi:10.1016/b978-044451980-1.50013-6 · Cited by 21
Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer’s Disease
Martins, I. J., & Creegan, R. (2014) · Health · doi:10.4236/health.2014.612190 · Cited by 18
Dietary cholesterol impairs memory and memory increases brain cholesterol and sulfatide levels.
Darwish, D. S., Wang, D., Konat, G. W., & Schreurs, B. G. (2010) · Behavioral Neuroscience · doi:10.1037/a0018253 · Cited by 17
Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
Rembach, A., Ryan, T. M., Roberts, B. R., Doecke, J. D., Wilson, W. J., Watt, A. D., Barnham, K. J., & Masters, C. L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.59 · Cited by 18
Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease
Tong, M., Leão, R. A. C., Vimbela, G. V., Yalcin, E. B., Kay, J., Krotow, A., & de la Monte, S. M. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.010 · Cited by 17

Authors: Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Han, Xianlin
ORCID: Han, Xianlin
Morris, John C.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2002-08
Volume: 82
Issue: 4
Pages: 809-818
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1046/j.1471-4159.2002.00997.x
OpenAlex: W1594975246
Cited by: 626
References: 56
Citations by year: 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
FWCI: 7.61
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p41rr000954-34)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
National Center for Research Resources (P41RR00954-240043)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks